Robeco Institutional Asset Management
VIVO

Robeco Institutional Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Robeco Institutional Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-45,697
Closed -$809K – 864
2016
Q4 		$809K Sell
45,697
-222,234
-83% -$3.9M 0.01% 613
2016
Q3 		$5.17M Hold
267,931
– – 0.04% 374
2016
Q2 		$5.22M Hold
267,931
– – 0.04% 361
2016
Q1 		$5.52M Buy
+267,931
New +$5.28M 0.04% 342

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Robeco Institutional Asset Management's VIVO Position: Q1 2017 in Review

Robeco Institutional Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2017, closing a stake of 45,697 shares — an estimated $809K sold.

Robeco Institutional Asset Management first reported a position in VIVO in Q1 2016 and held it in 4 quarters. The position peaked at $5.52M in Q1 2016. 165 funds tracked by Wall St. Rank hold VIVO as of Q1 2017.

  • Robeco Institutional Asset Management reported no remaining Meridian Bioscience Inc position as of Q1 2017 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 45,697 Meridian Bioscience Inc shares in Q1 2017, an estimated $809K.
  • Robeco Institutional Asset Management first reported a position in Meridian Bioscience Inc in Q1 2016 and held it in 4 quarters.
  • Robeco Institutional Asset Management's Meridian Bioscience Inc position peaked at $5.52M in Q1 2016.
  • 165 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2017.

Based on Robeco Institutional Asset Management's 13F filing for Q1 2017, filed 15 May 2017.